Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Fludarabine (Primary) ; Melphalan (Primary)
- Indications Haematological malignancies; Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 29 Jan 2018 Status changed from not yet recruiting to recruiting.
- 15 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 22 Dec 2017.
- 24 Oct 2017 Planned initiation date changed from 1 Jul 2017 to 1 Dec 2017.